Steven James Gray

  • 2708 Citations
  • 24 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Steven James Gray is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Dependovirus Medicine & Life Sciences
Genetic Therapy Medicine & Life Sciences
Genes Medicine & Life Sciences
Giant Axonal Neuropathy Medicine & Life Sciences
Transgenes Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Globoid Cell Leukodystrophy Medicine & Life Sciences
Rett Syndrome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 2708 Citations
  • 24 h-Index
  • 47 Article
  • 10 Review article
  • 5 Comment/debate
  • 1 Chapter
1 Citation (Scopus)

Advancing the pathologic phenotype of giant axonal neuropathy: Early involvement of the ocular lens

Armao, D., Bouldin, T. W., Bailey, R. M., Hooper, J. E., Bharucha, D. X. & Gray, S. J., Feb 1 2019, In : Orphanet Journal of Rare Diseases. 14, 1, 27.

Research output: Contribution to journalArticle

Open Access
Giant Axonal Neuropathy
Crystalline Lens
Intermediate Filaments
Inclusion Bodies
2 Citations (Scopus)

Efficacy of a Bicistronic Vector for Correction of Sandhoff Disease in a Mouse Model

Woodley, E., Osmon, K. J. L., Thompson, P., Richmond, C., Chen, Z., Gray, S. J. & Walia, J. S., Mar 15 2019, In : Molecular Therapy - Methods and Clinical Development. 12, p. 47-57 11 p.

Research output: Contribution to journalArticle

Sandhoff Disease
GM2 Gangliosidosis
Hexosaminidase A
Tay-Sachs Disease
14 Citations (Scopus)

Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy

Bailey, R. M., Armao, D., Nagabhushan Kalburgi, S. & Gray, S. J., Jun 15 2018, In : Molecular Therapy - Methods and Clinical Development. 9, p. 160-171 12 p.

Research output: Contribution to journalArticle

Giant Axonal Neuropathy
Genetic Therapy
Intermediate Filaments
Clinical Trials, Phase I
Viral Genes

Erratum: Correction: Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation (PloS one (2018) 13 6 (e0198154))

Ramsingh, A. I., Gray, S. J., Reilly, A., Koday, M., Bratt, D., Koday, M. T., Munson, P., Murnane, R., Smedley, J., Hu, Y., Messer, A. & Fuller, D. H., Jan 1 2018, In : PLoS One. 13, 11, p. e0207077

Research output: Contribution to journalComment/debate

10 Citations (Scopus)

Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease

Mitchell, N. L., Russell, K. N., Wellby, M. P., Wicky, H. E., Schoderboeck, L., Barrell, G. K., Melzer, T. R., Gray, S. J., Hughes, S. M. & Palmer, D. N., Jan 1 2018, (Accepted/In press) In : Molecular Therapy.

Research output: Contribution to journalArticle

Neuronal Ceroid-Lipofuscinoses
Genetic Therapy